Title 25, Public Health and Environment
0 chapters · 1,375 sections in this title.
Colo. Rev. Stat. § 25-45-101 Short title
0.2K chars
This article shall be known and may be cited as the Right to Try Act. Source: L. 2014: Entire article added, (HB 14-1281), ch. 220, p. 823, � 1, effective May 17.
Colo. Rev. Stat. § 25-45-102 Legislative declaration
1.6K chars
(1) For purposes of this part 1, the general assembly finds and declares that: (a) The process of approval for investigational drugs, biological products, and devices in the United States protects future patients from premature, ineffective, and unsafe medications and treatments …
Colo. Rev. Stat. § 25-45-103 Definitions
7.2K chars
As used in this part 1, unless the context otherwise requires: (1) (a) Eligible patient means a person who has: (I) A terminal illness, attested to by the patient's treating physician; (II) Considered all other treatment options currently approved by the United States food and dr…
Colo. Rev. Stat. § 25-45-104 Drug manufacturers - availability of investigational drugs, biological products, or devices - costs - insurance coverage
2.7K chars
(1) A manufacturer of an investigational drug, biological product, or device may make available the manufacturer’s investigational drug, biological product, or device to eligible patients pursuant to this part 1. This part 1 does not require that a manufacturer make available an …
Colo. Rev. Stat. § 25-45-105 Action against health-care provider’s license or medicare certification prohibited
0.7K chars
Notwithstanding any other law, a licensing board may not revoke, fail to renew, suspend, or take any action against a health-care provider’s license issued pursuant to title 12, C.R.S., based solely on the health-care provider’s recommendations to an eligible patient regarding ac…
Colo. Rev. Stat. § 25-45-106 Access to investigational drugs, biological products, and devices
0.3K chars
An official, employee, or agent of this state shall not block or attempt to block an eligible patient’s access to an investigational drug, biological product, or device. Counseling, advice, or a recommendation consistent with medical standards of care from a licensed health-care …
Colo. Rev. Stat. § 25-45-107 No cause of action created
0.7K chars
This part 1 does not create a private cause of action against a manufacturer of an investigational drug, biological product, or device, or against any other person or entity involved in the care of an eligible patient using the investigational drug, biological product, or device,…
Colo. Rev. Stat. § 25-45-108 Effect on health-care coverage
0.2K chars
Nothing in this section affects the mandatory health-care coverage for participation in clinical trials pursuant to section 10-16-106 (20), C.R.S. Source: L. 2014: Entire article added, (HB 14-1281), ch. 220, p. 827, � 1, effective May 17.
Colo. Rev. Stat. § 25-45-201 Legislative declaration
1.3K chars
(1) For purposes of this part 2, the general assembly finds and determines that: (a) Some public and private entities operating under federal standards for the protection of human subjects in research develop individualized investigational drugs, biological products, and devices …
Colo. Rev. Stat. § 25-45-202 Definitions
7.7K chars
As used in this part 2, unless the context otherwise requires: (1) Eligible facility means an institution operating under the federalwide assurance for the protection of human subjects in accordance with 45 CFR 46 and 42 U.S.C. sec. 289a. (2) Eligible patient means an individual …
Colo. Rev. Stat. § 25-45-203 Drug manufacturers - authorized access to and use of individualized investigational drugs, biological products, or devices - costs
1.6K chars
(1) A manufacturer operating within an eligible facility and in accordance with applicable federal law may make available to an eligible patient, and an eligible patient may request, the manufacturer’s individualized investigational drug, biological product, or device from the el…
Colo. Rev. Stat. § 25-45-204 Action against health-care provider’s license or medicare certification prohibited
0.7K chars
Notwithstanding any other law, a licensing board shall not revoke, fail to renew, suspend, or take other action against a health-care provider’s license issued pursuant to title 12 based solely on the health-care provider’s recommendation to an eligible patient regarding access t…
Colo. Rev. Stat. § 25-45-205 Access to individualized investigational drugs, biological products, and devices - prohibition on state action
0.3K chars
An official, employee, or agent of this state shall not block or attempt to block an eligible patient’s access to an individualized investigational drug, biological product, or device. Counseling, advice, or a recommendation consistent with medical standards of care from a licens…
Colo. Rev. Stat. § 25-45-206 No cause of action created
0.6K chars
This part 2 does not create a private right of action against a manufacturer of an individualized investigational drug, biological product, or device, or against an individual or entity involved in the care of an eligible patient using an individualized investigational drug, biol…
Colo. Rev. Stat. § 25-45-207 Effect on health-care coverage
0.2K chars
Nothing in this part 2 affects a health insurance provider’s obligation to provide coverage for an insured’s participation in a clinical trial pursuant to section 10-16-104 (20).